Evidence for a role of CRM1 in signal-mediated nuclear protein export - PubMed
- ️Wed Jan 01 1997
Evidence for a role of CRM1 in signal-mediated nuclear protein export
B Ossareh-Nazari et al. Science. 1997.
Abstract
Chromosome maintenance region 1 (CRM1), a protein that shares sequence similarities with the karyopherin beta family of proteins involved in nuclear import pathway, was shown to form a complex with the leucine-rich nuclear export signal (NES). This interaction was inhibited by leptomycin B, a drug that prevents the function of the CRM1 protein in yeast. To analyze the role of the CRM1-NES interaction in nuclear export, a transport assay based on semipermeabilized cells was developed. In this system, which reconstituted NES-, cytosol-, and energy-dependent nuclear export, leptomycin B specifically blocked export of NES-containing proteins. Thus, the CRM1 protein could act as a NES receptor involved in nuclear protein export.
Similar articles
-
Huang TT, Kudo N, Yoshida M, Miyamoto S. Huang TT, et al. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1014-9. doi: 10.1073/pnas.97.3.1014. Proc Natl Acad Sci U S A. 2000. PMID: 10655476 Free PMC article.
-
Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1.
Kudo N, Wolff B, Sekimoto T, Schreiner EP, Yoneda Y, Yanagida M, Horinouchi S, Yoshida M. Kudo N, et al. Exp Cell Res. 1998 Aug 1;242(2):540-7. doi: 10.1006/excr.1998.4136. Exp Cell Res. 1998. PMID: 9683540
-
CRM1 is responsible for intracellular transport mediated by the nuclear export signal.
Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M, Yanagida M, Nishida E. Fukuda M, et al. Nature. 1997 Nov 20;390(6657):308-11. doi: 10.1038/36894. Nature. 1997. PMID: 9384386
-
Nucleo-cytoplasmic transport of proteins as a target for therapeutic drugs.
Yashiroda Y, Yoshida M. Yashiroda Y, et al. Curr Med Chem. 2003 May;10(9):741-8. doi: 10.2174/0929867033457791. Curr Med Chem. 2003. PMID: 12678777 Review.
-
Nuclear export of proteins and drug resistance in cancer.
Turner JG, Dawson J, Sullivan DM. Turner JG, et al. Biochem Pharmacol. 2012 Apr 15;83(8):1021-32. doi: 10.1016/j.bcp.2011.12.016. Epub 2011 Dec 20. Biochem Pharmacol. 2012. PMID: 22209898 Free PMC article. Review.
Cited by
-
Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor.
Sui M, Xiong M, Li Y, Zhou Q, Shen X, Jia D, Gou M, Sun Q. Sui M, et al. Int J Nanomedicine. 2021 Apr 14;16:2833-2847. doi: 10.2147/IJN.S266398. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33883894 Free PMC article.
-
Liu Cj, Wang H, Zhao Z, Yu S, Lu YB, Meyer J, Chatterjee G, Deschamps S, Roe BA, Lengyel P. Liu Cj, et al. Mol Cell Biol. 2000 Sep;20(18):7024-36. doi: 10.1128/MCB.20.18.7024-7036.2000. Mol Cell Biol. 2000. PMID: 10958697 Free PMC article.
-
The nucleocytoplasmic transport of viral proteins.
Ding Q, Zhao L, Guo H, Zheng AC. Ding Q, et al. Virol Sin. 2010 Apr;25(2):79-85. doi: 10.1007/s12250-010-3099-z. Epub 2010 Apr 9. Virol Sin. 2010. PMID: 20960304 Free PMC article. Review.
-
Smith JJ, Richardson DA, Kopf J, Yoshida M, Hollingsworth RE, Kornbluth S. Smith JJ, et al. Mol Cell Biol. 2002 Mar;22(5):1412-23. doi: 10.1128/MCB.22.5.1412-1423.2002. Mol Cell Biol. 2002. PMID: 11839808 Free PMC article.
-
Renault-Mihara F, Beuvon F, Iturrioz X, Canton B, De Bouard S, Léonard N, Mouhamad S, Sharif A, Ramos JW, Junier MP, Chneiweiss H. Renault-Mihara F, et al. Mol Biol Cell. 2006 Dec;17(12):5141-52. doi: 10.1091/mbc.e05-11-1072. Epub 2006 Sep 20. Mol Biol Cell. 2006. PMID: 16987961 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases